Abstract

BackgroundGastric adenocarcinoma of the fundic gland type (GA-FG) has been added to the 2019 edition of the World Health Organization’s list of digestive system-associated cancers. This lesion differentiates toward the fundic gland and mostly involves chief cell-predominant differentiation with low-grade cytology. Clinicians and pathologists are still unaware of this rare disease; consequently, some cases are incorrectly diagnosed. This study aimed to investigate the clinicopathological features of GA-FG using retrospective analyses of endoscopic and pathological findings.Materials and methodsSamples were collected from patients diagnosed with GA-FG. The clinical courses of all patients were monitored prospectively and reviewed retrospectively. Available clinical information, endoscopic features, pathological appearance, and follow-up data were assessed. Immunohistochemistry [mucin (MUC) 2, MUC5, MUC6, P53, CDX2, Ki67, SYN, CD56, CGA, β-catenin, and pepsinogen-I] was examined using Envision two-step method.ResultsEight cases of endoscopic submucosal dissection (ESD) were obtained from our institution. Patient age ranged from 48 to 80 years (mean, 65 years). Some patients were on acid-suppressing medication. Most lesions were located in the upper third (n = 7) and one was in the middle third of the stomach. Six lesions were of the superficial flat type, whereas two were of the superficial elevated type. Narrow-band imaging using magnifying endoscopy showed irregular microvascular patterns (MVPs) in four cases and regular MVPs in the remaining cases. All lesions were primarily solitary and ~ 6 mm in diameter (largest, 12 mm). The main body of the tumors were localized in the mucosal layer, of which six cases invade into the submucosal layer. Well-formed glands of chief cells were predominant. Tumor cells were positive for pepsinogen-I, MUC6, SYN, and CD56. Lymphatic and vascular infiltration and metastatic and recurrent disease were not observed in any case.ConclusionGA-FG, a well-differentiated adenocarcinoma with mild atypia, can be completely removed using ESD, with a favorable prognosis in patients.

Highlights

  • Gastric adenocarcinoma of the fundic gland type (GAFG), a new rare variant of gastric adenocarcinoma, presents with atypical cells with differentiation toward the fundic gland

  • Tumor cells were positive for pepsinogen-I, MUC6, SYN, and CD56

  • According to the 5th edition of the World Health Organization’s (WHO 2019) classification of digestive system tumors, the characteristic oxyntic gland differentiation in Gastric adenocarcinoma of the fundic gland type (GA-FG) can be divided into three subcategories on the basis of the tumor composition, namely, chief cell predominant (~ 99% of reported cases), parietal cell predominant, and mixed phenotype [1]

Read more

Summary

Introduction

Gastric adenocarcinoma of the fundic gland type (GAFG), a new rare variant of gastric adenocarcinoma, presents with atypical cells with differentiation toward the fundic gland. Tsukamoto was the first to report a case of adenocarcinoma with chief-cell differentiation, which was named “gastric adenocarcinoma of fundic gland mucosa type” in 2007 [2]. Ueyama proposed a new histological type of gastric cancer with differentiation toward the fundic gland, named “gastric adenocarcinoma of the fundic gland type” in 2010 [3]. Gastric adenocarcinoma of the fundic gland type (GA-FG) has been added to the 2019 edition of the World Health Organization’s list of digestive system-associated cancers. This lesion differentiates toward the fundic gland and mostly involves chief cell-predominant differentiation with low-grade cytology. This study aimed to investigate the clinicopathological features of GA-FG using retrospective analyses of endoscopic and pathological findings

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call